190 related articles for article (PubMed ID: 19713988)
41. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
Arriola V; Tischendorf J; Musuuza J; Barker A; Rozelle JW; Safdar N
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1408-1417. PubMed ID: 27677811
[TBL] [Abstract][Full Text] [Related]
42. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
[TBL] [Abstract][Full Text] [Related]
43. Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.
Cunningham R
CMAJ; 2006 Sep; 175(7):757. PubMed ID: 17001056
[No Abstract] [Full Text] [Related]
44. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Freedberg DE; Toussaint NC; Chen SP; Ratner AJ; Whittier S; Wang TC; Wang HH; Abrams JA
Gastroenterology; 2015 Oct; 149(4):883-5.e9. PubMed ID: 26164495
[TBL] [Abstract][Full Text] [Related]
45. Is Clostridium difficile associated with the '4C' antibiotics? A retrospective observational study in diabetic foot ulcer patients.
Collier A; McLaren J; Godwin J; Bal A
Int J Clin Pract; 2014 May; 68(5):628-32. PubMed ID: 24499256
[TBL] [Abstract][Full Text] [Related]
46. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
[TBL] [Abstract][Full Text] [Related]
47. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
Choudhry MN; Soran H; Ziglam HM
QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
[TBL] [Abstract][Full Text] [Related]
48. Acid suppression and the risk of Clostridium difficile infection.
Mezoff EA; Cohen MB
J Pediatr; 2013 Sep; 163(3):627-30. PubMed ID: 23759424
[No Abstract] [Full Text] [Related]
49. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
[TBL] [Abstract][Full Text] [Related]
50. Proton pump inhibitor use may be associated with an increased risk of Clostridium difficile infection.
Stevens V; van Wijngaarden E
Evid Based Med; 2013 Oct; 18(5):193-4. PubMed ID: 23220471
[No Abstract] [Full Text] [Related]
51. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
52. When proton pump inhibitors fail.
Kahrilas PJ
Clin Gastroenterol Hepatol; 2008 May; 6(5):482-3. PubMed ID: 18378500
[No Abstract] [Full Text] [Related]
53. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.
Chandra S; Agarwal D; Surana A
Am J Gastroenterol; 2013 Feb; 108(2):277-8. PubMed ID: 23381074
[No Abstract] [Full Text] [Related]
54. Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review.
Anjewierden S; Han Z; Foster CB; Pant C; Deshpande A
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):420-426. PubMed ID: 30841948
[TBL] [Abstract][Full Text] [Related]
55. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
Biswal S
Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
[TBL] [Abstract][Full Text] [Related]
56. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
57. Clostridium difficile: an emerging pathogen in children.
Khalaf N; Crews JD; DuPont HL; Koo HL
Discov Med; 2012 Aug; 14(75):105-13. PubMed ID: 22935207
[TBL] [Abstract][Full Text] [Related]
58. Clostridium difficile infection in the intensive care unit.
Riddle DJ; Dubberke ER
Infect Dis Clin North Am; 2009 Sep; 23(3):727-43. PubMed ID: 19665092
[TBL] [Abstract][Full Text] [Related]
59. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.
Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL
J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261
[TBL] [Abstract][Full Text] [Related]
60. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics.
Kim JS; Ward KK; Shah NR; Saenz CC; McHale MT; Plaxe SC
Support Care Cancer; 2013 Nov; 21(11):3103-7. PubMed ID: 23839499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
